F-star Biotechnology

F-star is a clinical-stage biopharmaceutical company developing bispecific antibody immuno-oncology products selected for their potential to transform the treatment of cancer. Through the application of its highly efficient Modular Antibody Technology™ platform, F-star is the only biotechnology company able to create bispecific antibodies, where the second binding site is in the constant Fc region of an antibody, offering unprecedented ease in the discovery, development and manufacturing of bispecific antibody products. The strength of the technology and programmes has been leveraged through partnerships with leading biopharmaceutical companies including, AbbVie, Bristol-Myers Squibb, Merck Serono and Boehringer Ingelheim.
Company growth
Type
Private
HQ
Cambridgeshire, GB
Founded
2006
Size (employees)
63 (est)
F-star Biotechnology was founded in 2006 and is headquartered in Cambridgeshire, GB

Key People at F-star Biotechnology

Kevin FitzGerald

Kevin FitzGerald

CEO
John Haurum

John Haurum

CEO
Eugen Stermetz

Eugen Stermetz

CFO
Jane Dancer

Jane Dancer

coo

F-star Biotechnology Office Locations

F-star Biotechnology has offices in Cambridgeshire, Wien
Cambridgeshire, GB
Wien, AT

F-star Biotechnology Metrics

F-star Biotechnology Summary

Founding Date

2006

Total Funding

$57.3 M

Latest funding size

$9.4 M

Time since last funding

over 3 years

Investors

We estimate that F-star Biotechnology's latest funding round in October 2013 was $9.4 M. In total, F-star Biotechnology has raised $57.3 M

F-star Biotechnology Financials

We estimate that F-star Biotechnology's revenue is £7.75 M in FY, 2015 which is 8.45% increase from the previous period.
FY, 2015FY, 2014FY, 2013

Revenue

£7.75 M£7.14 M£2.41 M

Revenue growth, %

8.4%196.3%
We estimate that F-star Biotechnology's current employees are approximately 24% female and 76% male.

F-star Biotechnology Online Presence

F-star Biotechnology Company Life

You may also be interested in